News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,036 Results
Type
Article (15961)
Company Profile (76)
Press Release (215999)
Section
Business (67997)
Career Advice (362)
Deals (10542)
Drug Delivery (14)
Drug Development (31239)
Employer Resources (22)
FDA (6832)
Job Trends (5381)
News (118904)
Policy (11880)
Tag
Academia (1263)
Alliances (19956)
Alzheimer's disease (427)
Approvals (6858)
Artificial intelligence (70)
Bankruptcy (55)
Best Places to Work (4424)
Biotechnology (56)
Breast cancer (90)
Cancer (671)
Cardiovascular disease (40)
Career advice (318)
Cell therapy (98)
Clinical research (24652)
Collaboration (237)
Compensation (45)
COVID-19 (1130)
C-suite (50)
Data (708)
Diabetes (52)
Diagnostics (4536)
Drug discovery (37)
Earnings (23075)
Events (29659)
Executive appointments (120)
FDA (7056)
Funding (148)
Gene therapy (75)
GLP-1 (231)
Government (1550)
Healthcare (5394)
Infectious disease (1168)
Inflammatory bowel disease (49)
Interviews (45)
IPO (4271)
Job creations (1186)
Job search strategy (298)
Layoffs (106)
Legal (1760)
Lung cancer (103)
Lymphoma (45)
Manufacturing (73)
Medical device (3234)
Medtech (3234)
Mergers & acquisitions (6324)
Metabolic disorders (128)
Neuroscience (533)
NextGen Class of 2024 (1518)
Non-profit (1040)
Northern California (677)
Obesity (75)
Opinion (48)
People (20509)
Phase I (7086)
Phase II (10188)
Phase III (9501)
Pipeline (227)
Postmarket research (1032)
Preclinical (3733)
Press Release (52)
Radiopharmaceuticals (103)
Rare diseases (87)
Real estate (2667)
Regulatory (9137)
Research institute (1307)
Resumes & cover letters (46)
Southern California (486)
Startups (1371)
United States (4961)
Vaccines (194)
Weight loss (40)
Date
Last 7 days (271)
Last 30 days (875)
Last 365 days (12989)
2024 (12695)
2023 (14969)
2022 (19982)
2021 (21089)
2020 (18834)
2019 (14243)
2018 (11013)
2017 (12737)
2016 (11957)
2015 (13703)
2014 (10226)
2013 (8583)
2012 (9466)
2011 (9580)
2010 (8335)
Location
Africa (241)
Arizona (40)
Asia (14459)
Australia (2373)
California (1378)
Canada (385)
China (119)
Colorado (49)
Connecticut (64)
Delaware (42)
Europe (42741)
Florida (123)
Illinois (82)
Indiana (63)
Maryland (172)
Massachusetts (1018)
Michigan (70)
Minnesota (78)
New Jersey (448)
New York (370)
North Carolina (227)
Northern California (677)
Ohio (71)
Pennsylvania (182)
South America (317)
Southern California (486)
Texas (178)
Utah (58)
Washington State (135)
232,036 Results for "european molecular biology laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virscio Extends Translational Expertise and Research Services to Molecular Biology
October 22, 2024
·
1 min read
Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.
The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million patients* in Europe.
June 28, 2024
·
2 min read
Press Releases
Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities
December 13, 2024
·
3 min read
Press Releases
BostonGene to Participate in the European Federation of Laboratory Medicine Strategic Conference 2024
September 19, 2024
·
2 min read
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Biotech Bay
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Cytokinetics, Incorporated announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium , May 17th, 2024 at the Mission Bay Conference Center in San Francisco.
May 17, 2024
·
5 min read
Collaboration
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
October 28, 2024
·
2 min read
·
Tristan Manalac
BioCapital
Sapio Sciences Unveils Enhanced Molecular Biology Toolkit
Sapio Sciences, the science-awareTM lab informatics platform, announced Sapio ELNSM release 24.5.
May 7, 2024
·
3 min read
Press Releases
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting
November 21, 2024
·
3 min read
Business
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union.
April 25, 2024
·
3 min read
1 of 23,204
Next
